ReviewPharmaceuticals (Basel, Switzerland)2026
GLP-1 RAs for Treating Metabolic Dysfunction-Associated Steatosis Liver Disease: From GLP-1 Discovery to FDA Approval: A Comprehensive Narrative Review.
Olfa Khalifa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.